1997
DOI: 10.1159/000159204
|View full text |Cite
|
Sign up to set email alerts
|

Resistance and Conduit Arteries following Converting Enzyme Inhibition in Hypertension

Abstract: Alterations in the structure of resistance and conduit arteries are a characteristic hallmark in hypertension. Studies carried out in hypertensive rats and in humans suggest that angiotensin I-converting enzyme inhibition has an effect on arterial structure of resistance arteries. In hypertensive rats the reduction of the media to lumen ratio is dose-dependent and significantly different from the effects of other antihypertensive agents at doses causing an equal degree of blood pressure reduction. In large con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
33
0
3

Year Published

1998
1998
2014
2014

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 63 publications
(36 citation statements)
references
References 90 publications
(162 reference statements)
0
33
0
3
Order By: Relevance
“…28 Inhibition of angiotensin-converting enzyme has been shown to reduce arterial stiffness, 29 as has a low-salt diet. 30 Additionally, we have previously shown in this same population a strong relationship between obesity and larger arterial diameters and wall thickening.…”
Section: Discussionmentioning
confidence: 99%
“…28 Inhibition of angiotensin-converting enzyme has been shown to reduce arterial stiffness, 29 as has a low-salt diet. 30 Additionally, we have previously shown in this same population a strong relationship between obesity and larger arterial diameters and wall thickening.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Several arguments have suggested that the antihypertensive agents related to the renin-angiotensin system act, to a large extent, not only on arterioles but also on the large arterial wall. 3 Angiotensin II (Ang II), the main effector peptide of the reninangiotensin system has long been known to play a major role in the regulation of BP and body fluid homeostasis. Moreover, Ang II has been reported to induce hyperplasia and/or hypertrophy in cultured aortic smooth muscle cells [4][5][6][7] in small resistance arteries 8 and in cardiomyocytes.…”
Section: Introductionmentioning
confidence: 99%
“…2,3,6 -8 In genetic models of hypertension in rats, the ACEI ϩ D combination was shown to induce a significantly more pronounced pressure-independent decrease in arterial stiffness and reduction of aortic collagen accumulation than that of each component given alone. 9,10 In middle-aged patients with hypertension, although D induces only minor changes in large artery diameter and stiffness, ACEIs and, mostly, the DϩACEI combination are able to normalize arterial stiffness and wall thickness. 10 Thus, it is relevant to evaluate whether a fixed ACEIϩD combination is a suitable therapy for selectively reducing SBP and PP by improving arterial stiffness.…”
mentioning
confidence: 99%
“…9,10 In middle-aged patients with hypertension, although D induces only minor changes in large artery diameter and stiffness, ACEIs and, mostly, the DϩACEI combination are able to normalize arterial stiffness and wall thickness. 10 Thus, it is relevant to evaluate whether a fixed ACEIϩD combination is a suitable therapy for selectively reducing SBP and PP by improving arterial stiffness.…”
mentioning
confidence: 99%